THE US Patent Office has
granted ‘preclinical stem cell
engineering company’ ViaCyte
three patents for methods it has
developed for use in possible stem
cell treatments for diabetes.
The patents extend to its
‘Methods for Increasing Definitive
Endoderm Production’, ‘Methods
of Producing Pancreatic
Hormones’ and the company’s
‘Definitive Endoderm’ production
procedure.The above article was sent to subscribers in Pharmacy Daily's issue from 07 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 10
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.